These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2568151

  • 21. Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice.
    Date I, Felten SY, Olschowka JA, Felten DL.
    Exp Neurol; 1990 Mar; 107(3):197-207. PubMed ID: 2307201
    [Abstract] [Full Text] [Related]

  • 22. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury.
    Reinhard JF, Miller DB, O'Callaghan JP.
    Neurosci Lett; 1988 Dec 19; 95(1-3):246-51. PubMed ID: 3265770
    [Abstract] [Full Text] [Related]

  • 23. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
    Liu J, Wang MW, Gu P, Ma QY, Wang YY, Geng Y, Yuan ZY, Cui DS, Zhang ZX, Ma L, Zhang BH, Zhou MG, Zhu AP.
    Brain Res; 2010 Jul 23; 1345():213-20. PubMed ID: 20546706
    [Abstract] [Full Text] [Related]

  • 24. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
    Wiener HL, Hashim A, Lajtha A, Sershen H.
    J Neurosci Res; 1989 Jul 23; 23(3):326-9. PubMed ID: 2504936
    [Abstract] [Full Text] [Related]

  • 25. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M, Morissette M, Tanguay B, Callier S, Di Paolo T.
    Synapse; 2003 Jan 23; 47(1):10-4. PubMed ID: 12422368
    [Abstract] [Full Text] [Related]

  • 26. Early and late effects of systemically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase activity in vitro and on tyrosine hydroxylation in tissue slices of mouse striatum.
    Hirata Y, Nagatsu T.
    Neurosci Lett; 1986 Jul 24; 68(2):245-8. PubMed ID: 2875421
    [Abstract] [Full Text] [Related]

  • 27. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A, Mura A, Hengerer B, Feldon J, Ferger B.
    Behav Brain Res; 2004 Oct 05; 154(2):375-83. PubMed ID: 15313025
    [Abstract] [Full Text] [Related]

  • 28. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U, Ramsay KA, Jiang H, Jackson-Lewis V, Donaldson D, Fernando S, Ferreira M, Przedborski S.
    Exp Neurol; 1994 Apr 05; 126(2):195-204. PubMed ID: 7925820
    [Abstract] [Full Text] [Related]

  • 29. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice.
    Beal MF, Matthews RT, Tieleman A, Shults CW.
    Brain Res; 1998 Feb 02; 783(1):109-14. PubMed ID: 9479058
    [Abstract] [Full Text] [Related]

  • 30. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR, Fields V, Pflibsen L, Salvatore MF, Meshul CK.
    Neurobiol Dis; 2012 Mar 02; 45(3):1051-67. PubMed ID: 22198503
    [Abstract] [Full Text] [Related]

  • 31. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 32. Decreased Mcl-1 protein level in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lu E, Sarkar S, Raymick J, Paule MG, Gu Q.
    Brain Res; 2018 Jan 01; 1678():432-439. PubMed ID: 29158176
    [Abstract] [Full Text] [Related]

  • 33. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
    Date I, Felten DL, Felten SY.
    Brain Res; 1990 Jun 11; 519(1-2):266-76. PubMed ID: 1975765
    [Abstract] [Full Text] [Related]

  • 34. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse.
    Hadjiconstantinou M, Fitkin JG, Dalia A, Neff NH.
    J Neurochem; 1991 Aug 11; 57(2):479-82. PubMed ID: 1677029
    [Abstract] [Full Text] [Related]

  • 35. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
    Bhargava HN, Perlow MJ.
    Toxicol Lett; 1988 Mar 11; 40(3):219-24. PubMed ID: 3258448
    [Abstract] [Full Text] [Related]

  • 36. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
    Manaye KF, Sonsalla PK, Barnett G, Heikkila RE, Woodward DJ, Smith WK, German DC.
    Brain Res; 1989 Jul 10; 491(2):307-15. PubMed ID: 2765888
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Hirata Y, Nagatsu T.
    Brain Res; 1985 Jun 24; 337(1):193-6. PubMed ID: 2860954
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.